# Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery

> **NCT00235521** · NA · COMPLETED · sponsor: **Heidelberg University** · enrollment: 15 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** aerosolized iloprost

## Key facts

- **NCT ID:** NCT00235521
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235521, "Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT00235521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*